Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-04 Exercise |
2025-04-07 4:15 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Seehra Jasbir CHIEF EXECUTIVE OFFICER |
49,367 | $0.3 | 554,667 (Direct) |
View |
| 2025-04-04 Exercise |
2025-04-07 4:15 pm |
N/A 2028-03-25 |
Keros Therapeutics Inc. | KROS | Seehra Jasbir CHIEF EXECUTIVE OFFICER |
49,367 | $0 | 554,667 (Direct) |
View |
| 2024-02-23 Option Award |
2024-02-23 5:07 pm |
N/A 2034-02-22 |
Keros Therapeutics Inc. | KROS | Seehra Jasbir CHIEF EXECUTIVE OFFICER |
125,000 | $0 | 125,000 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 8:41 pm |
N/A 2034-02-12 |
Keros Therapeutics Inc. | KROS | Seehra Jasbir CHIEF EXECUTIVE OFFICER |
125,000 | $0 | 125,000 (Direct) |
View |
| 2023-04-08 Exercise |
2023-04-11 4:05 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Seehra Jasbir Chief Executive Officer |
4,000 | $0.48 | 297,943 (Direct) |
View |
| 2023-04-08 Exercise |
2023-04-11 4:05 pm |
N/A 2029-06-18 |
Keros Therapeutics Inc. | KROS | Seehra Jasbir Chief Executive Officer |
4,000 | $0 | 297,943 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-17 4:13 pm |
N/A 2033-02-15 |
Keros Therapeutics Inc. | KROS | Seehra Jasbir Chief Executive Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 08:28 am |
N/A 2032-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Seehra Jasbir Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-09 Exercise |
2022-06-10 4:12 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Seehra Jasbir Chief Executive Officer |
5,000 | $0.3 | 257,678 (Direct) |
View |
| 2022-06-09 Exercise |
2022-06-10 4:12 pm |
N/A 2028-03-25 |
Keros Therapeutics Inc. | KROS | Seehra Jasbir Chief Executive Officer |
5,000 | $0 | 257,678 (Direct) |
View |
| 2022-01-21 Option Award |
2022-01-25 4:17 pm |
N/A 2032-01-20 |
Keros Therapeutics Inc. | KROS | Seehra Jasbir Chief Executive Officer |
165,000 | $0 | 165,000 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-20 4:10 pm |
N/A 2031-05-19 |
Eloxx Pharmaceuticals Inc. | ELOX | Seehra Jasbir Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-01-10 Option Award |
2021-01-12 5:20 pm |
N/A 2031-01-09 |
Keros Therapeutics Inc. | KROS | Seehra Jasbir Chief Executive Officer |
127,200 | $0 | 127,200 (Direct) |
View |
| 2020-05-20 Option Award |
2020-05-22 4:10 pm |
N/A 2030-05-20 |
Eloxx Pharmaceuticals Inc. | ELOX | Seehra Jasbir Director |
20,000 | $0 | 20,000 (Direct) |
View |